Laurent Fischer - Aug 2, 2024 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Signature
/s/ John Rakow, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
Aug 2, 2024
Transactions value $
$0
Form type
4
Date filed
8/6/2024, 04:08 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADVM Stock Option (Right to Buy) Award $0 +200K $0.00 200K Aug 2, 2024 Common Stock 200K $7.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the total number of shares subject to the Option shall vest and become exercisable on the first anniversary of August 2, 2024 (the "Vesting Commencement Date"), and 1/36 of the total number of shares subject to the Option shall vest and become exercisable each month thereafter, such that all of the shares shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.